MiNK Therapeutics, Inc. INKT Q3 2025 earnings
Reported November 14, 2025 · Before market open
EPS-$0.65Beat by $0.21
EPS estimate-$0.86
Next report
Aug 13, 2026 (In 2 weeks)EPS estimate-$0.60
Versus estimates
Diluted EPS
Ask the moment MiNK Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did MiNK Therapeutics, Inc. report Q3 2025 earnings?
- MiNK Therapeutics, Inc. (INKT) reported Q3 2025 earnings on November 14, 2025 before market open.
- What were MiNK Therapeutics, Inc.'s Q3 2025 revenue and EPS?
- MiNK Therapeutics, Inc. reported eps of $-0.65 for Q3 2025.
- Did MiNK Therapeutics, Inc. beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-0.86 by $0.21.
- How did MiNK Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 30.0% from $-0.50.
- Where can I find MiNK Therapeutics, Inc.'s Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001193125-25-282905) directly on SEC EDGAR. The filing index links above go to sec.gov.